Publikationen, an denen er mitarbeitet AMAIA ESQUISÁBEL ALEGRÍA (21)

2007

  1. Proceedings del VIII Congreso de la Sociedad Española de Farmacia Industrial yGalénica

    Leioa : Universidad del País Vasco. Servicio Editorial = Euskal Herriko Unibertsitatea. Argitalpen Zerbitzua, 2007

2002

  1. Preparation and stability of agarose microcapsules containing BCG

    Journal of Microencapsulation, Vol. 19, Núm. 2, pp. 237-244

2000

  1. Effect of aging on the release of salbutamol sulfate from lipid matrices

    Spanish-Portuguese Conference on Controlled Drug Delivery (4º. Vitoria-Gasteiz. 2000)

  2. Effect of lecithins on BCG-alginate-PLL microcapsule particle size and stability upon storage

    Journal of Microencapsulation, Vol. 17, Núm. 3, pp. 363-372

1999

  1. Caracterización de la difusión de nutrientes a partir de microcápsulas de alginato-PLL y agarosa

    Congreso de la Asociación Española de Docentes de Farmacia Galénica (4º. Santiago de Compostela. 1999)

  2. Encapsulación de extractos alergénicos de Olea europaea en microcápsulas de PLGA

    Congreso de la Asociación Española de Docentes de Farmacia Galénica (4º. Santiago de Compostela. 1999)

1998

  1. Enhanced immune response after subcutaneous and oral immunization with biodegradable PLGA microspheres

    Journal of Controlled Release, Vol. 56, Núm. 1-3, pp. 63-73

  2. Enhanced immune response after subcutaneous oral immunization with biodegradablePLGA microspheres

    World Meeting APGI/APV (2º. París. 1998)

  3. Preparation and characterization of BCG loaded agarose microcapsules

    World Meeting APGI/APV (2º. París. 1998)

  4. Stability of BSA encapsulated into PLGA microspheres using page and capillary electrophoresis

    International Journal of Pharmaceutics, Vol. 169, Núm. 1, pp. 45-54

1997

  1. Determination of salbutamol enantiomers by high-performance capillary electrophoresis and its application to dissolution assays

    Journal of Pharmaceutical and Biomedical Analysis, Vol. 16, Núm. 2, pp. 357-366

  2. Immunopotentation of a model antigen by encapsulation into PLGA microspheres

    International Symposium of Particle Systems from formulation to production (Estambul. 1997)

  3. Influence of formulation variables on the in-vitro release of albumin from biodegradable microparticulate systems

    Journal of Microencapsulation, Vol. 14, Núm. 3, pp. 349-356

  4. Influence of pH on the salbutamol enantiomers release

    Proceedings of the Controlled Release Society

  5. Long-term immune response in mice following subcutaneous administration of BSA-PLGA microspheres

    Proceedings of the Controlled Release Society

  6. Optimizacion del tamano de particula de microesferas de PLGA con albumina bovina

    Informacion Tecnologica, Vol. 8, Núm. 4, pp. 327-332

  7. Preparation and characterization of BSA-PLGA microspheres suitable for oralvaccination

    Congreso Hispano-Luso de Liberación Controlada de Medicamentos (2º. Tenerife. 1997)

  8. Production of BCG alginate-PLL microcapsules by emulsification/internal gelation

    Journal of Microencapsulation, Vol. 14, Núm. 5, pp. 627-638

  9. Use of surfactants to reduce particle size of BCG-alginate microcapsules

    International Symposium of Particle Systems from formulation to production (Estambul. 1997)

1996

  1. Electroforesis capilar (I): conceptos fundamentales

    Industria farmacéutica: Equipos, procesos y tecnología, Núm. 2, pp. 35-40